Suppr超能文献

[Erdheim-Chester病外科治疗的初步研究]

[Preliminary study on surgical treatment of Erdheim-Chester disease].

作者信息

Zhang Yan, Zhang Bin, Li Jiazhen, Lu Xinchang, Zhang Yi

机构信息

Department of Orthopaedics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, 450052, P.R.China.

Department of Orthopaedics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, 450052,

出版信息

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018 Aug 15;32(8):1026-1031. doi: 10.7507/1002-1892.201802062.

Abstract

OBJECTIVE

To summarize the preliminary effectiveness of surgical treatment of Erdheim-Chester disease (ECD), so as to improve the understanding of the disease by orthopedic surgeons.

METHODS

The clinical data of 9 patients with ECD between December 2012 and October 2017 were retrospectively analysed. There were 6 males and 3 females with an median age of 42 years (range, 8-61 years). The disease duration was 4-59 months (mean, 39 months). There were 2 cases of multiple lesions, including 1 case involving soft tissue of the buttocks and bilateral tibia, 1 case involving the sinus, skull base, and proximal right tibia; 7 cases with single lesion, including 3 cases of right femoral neck, 1 case of proximal right tibia, 1 case of right humerus, and 2 cases of ribs. Nine patients were diagnosed according to clinical manifestations, imaging examination, and pathological diagnosis. Four patients underwent needle biopsy before operation and 5 patients were diagnosed by postoperative pathology examination. Five cases underwent lesional scraping and internal fixation, 1 case underwent bone scraping and bone grafting, and 3 cases underwent lesion resection. One of the multiple lesions was treated with interferon and hormone.

RESULTS

Nine patients underwent the surgery safely. There was no fever, wound exudation, infection, ., and the incisions healed by first intention. All the patients were followed up 4-59 months with an average of 31.4 months. One patient with bilateral tibia and hip soft tissue involvement continued to receive medical treatment, and the tumor was controlled without significant increasing. The remaining 8 patients were examined for X-ray films at 3, 6, and 12 months after surgery, the bone has been fused and the steel plate and intramedullary nail were firmly fixed, and no tumor recurrence was observed. At 1 year after surgery, the pain symptoms of the patients improved and returned to normal life; 3 of them who involving the right femoral neck walked freely, and the quality of life improved significantly.

CONCLUSION

ECD patients can achieve the purpose of eliminating lesions and relieving pain after surgical treatment, and the surgical treatment has the advantages of quick relief of pain, improved quality of life, small side effects, and low economic cost when compared with medical treatment.

摘要

目的

总结手术治疗厄氏病(ECD)的初步疗效,以提高骨科医生对该疾病的认识。

方法

回顾性分析2012年12月至2017年10月期间9例ECD患者的临床资料。其中男性6例,女性3例,中位年龄42岁(范围8 - 61岁)。病程4 - 59个月(平均39个月)。多发病变2例,其中1例累及臀部软组织及双侧胫骨,1例累及鼻窦、颅底及右胫骨近端;单发病变7例,其中右股骨颈3例,右胫骨近端1例,右肱骨1例,肋骨2例。9例患者均根据临床表现、影像学检查及病理诊断确诊。4例患者术前接受针吸活检,5例患者经术后病理检查确诊。5例行病灶刮除及内固定,1例行骨刮除及植骨,3例行病灶切除。多发病变中的1例采用干扰素及激素治疗。

结果

9例患者均安全接受手术。无发热、伤口渗液、感染等情况,切口均一期愈合。所有患者均获随访4 - 59个月,平均31.4个月。1例双侧胫骨及臀部软组织受累患者继续接受内科治疗,肿瘤得到控制,无明显增大。其余8例患者术后3、6、12个月行X线片检查,骨已融合,钢板及髓内钉固定牢固,未见肿瘤复发。术后1年,患者疼痛症状改善,恢复正常生活;其中3例累及右股骨颈者行走自如,生活质量明显提高。

结论

ECD患者手术治疗后可达到消除病灶、缓解疼痛的目的,与内科治疗相比,手术治疗具有止痛迅速、生活质量提高、副作用小、经济成本低等优点。

相似文献

1
[Preliminary study on surgical treatment of Erdheim-Chester disease].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018 Aug 15;32(8):1026-1031. doi: 10.7507/1002-1892.201802062.
2
[Clinical and pathological characteristics of Erdheim-Chester disease involving the lungs].
Zhonghua Jie He He Hu Xi Za Zhi. 2017 Aug 12;40(8):604-610. doi: 10.3760/cma.j.issn.1001-0939.2017.08.012.
4
Clinical presentation, imaging and response to interferon-alpha therapy in Erdheim-Chester disease: case-based review.
Rheumatol Int. 2020 Sep;40(9):1529-1536. doi: 10.1007/s00296-020-04627-z. Epub 2020 Jun 22.
9
Skull Base Manifestations of Erdheim-Chester Disease: A Case Series and Systematic Review.
Neurosurgery. 2019 Oct 1;85(4):E693-E701. doi: 10.1093/neuros/nyz027.
10
Erdheim-Chester disease: expanding the spectrum of cutaneous manifestations.
Br J Dermatol. 2020 Feb;182(2):405-409. doi: 10.1111/bjd.18153. Epub 2019 Sep 8.

引用本文的文献

本文引用的文献

1
Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
Blood. 2017 Jul 13;130(2):167-175. doi: 10.1182/blood-2016-12-757823. Epub 2017 May 16.
2
[Imaging features analysis of Erdheim-Chester].
Zhonghua Yi Xue Za Zhi. 2016 Aug 16;96(31):2478-81. doi: 10.3760/cma.j.issn.0376-2491.2016.31.008.
3
[Diagnosis and Treatment of Erdheim-Chester Disease -Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1256-9. doi: 10.7534/j.issn.1009-2137.2016.04.055.
4
Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults.
Ann Hematol. 2016 Apr;95(5):745-50. doi: 10.1007/s00277-016-2606-1. Epub 2016 Feb 9.
6
Erdheim-Chester disease and knee pain in a dialysis patient.
Clin Kidney J. 2014 Aug;7(4):402-5. doi: 10.1093/ckj/sfu031. Epub 2014 Apr 4.
7
Erdheim-Chester disease: a systematic review.
Crit Rev Oncol Hematol. 2015 Jul;95(1):1-11. doi: 10.1016/j.critrevonc.2015.02.004. Epub 2015 Feb 17.
9
Erdheim-Chester disease: characteristics and management.
Mayo Clin Proc. 2014 Jul;89(7):985-96. doi: 10.1016/j.mayocp.2014.01.023. Epub 2014 May 9.
10
[Non-Langerhans cell histiocytosis: a case report and literature review].
Zhonghua Xue Ye Xue Za Zhi. 2013 Jul;34(7):634-6. doi: 10.3760/cma.j.issn.0253-2727.2013.07.019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验